| Cat. No. |
Product Name |
Information |
| PC-70218 |
FAAH-IN-2
FAAH inhibitor
|
FAAH-IN-2 is a potent, selective, noncovalent FAAH inhibitor with IC50 of 28 nM toward human FAAH and 100 nM toward rat FAAH. |
| PC-60219 |
MK-4409
FAAH inhibitor
|
MK-4409 is a potent and selective, brain penetrant FAAH inhibitor with IC50 of 11 nM. |
| PC-45666 |
JNJ-42165279
FAAH inhibitor
|
JNJ-42165279 is a highly selective inhibitor of fatty acid amide hydrolase (FAAH) with IC50 of 70 nM for hFAAH. |
| PC-45699 |
BIA 10-2474
FAAH inhibitor
|
BIA 10-2474 is a potent FAAH inhibitor with IC50 of 4.9 nM in HEK293T cells expressing the human recombinant enzyme. |
| PC-42719 |
FAAH inhibitor 1
FAAH inhibitor
|
FAAH inhibitor 1 is a potent, and selective FAAH inhibitor with IC50 of 18 nM. |
| PC-42720 |
URB-597
FAAH inhibitor
|
URB-597 (KDS-4103) is a potent and selective FAAH inhibitor with IC50 of 4.6 nM. |
| PC-46002 |
O-Desmorpholinopropyl Gefitinib
FAAH inhibitor
|
O-Desmorpholinopropyl Gefitinib (FAAH-IN-2) is a metabolite of Gefitinib, which is a potent inhibitor of tyrosine phosporylation in EGFR, is a potent FAAH (fatty acid amide hydrolase) inhibitor. |
| PC-42721 |
LY2183240
FAAH inhibitor
|
LY2183240 is a highly potent blocker of anandamide uptake with IC50 of 270 pM in cellular assay. |
| PC-21982 |
JNJ-1661010
FAAH inhibitor
|
JNJ-1661010 (Takeda-25) is a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50 of 34 and 33 nM for rat FAAH and human FAAH, respectively. |
| PC-60986 |
ASP 3652
|
A potent, selective, peripherally active and orally available FAAH inhibitor for treatment of chronic prostatitis/chronic pelvic pain syndrome.. |
